01 1Aurobindo Pharma Limited
01 1SITAGLIPTIN PHOSPHATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-27
Pay. Date : 2018-06-29
DMF Number : 32940
Submission : 2018-06-29
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SITAGLIPTIN PHOSPHATE, with a corresponding US DMF Number 32940.
Remarkably, this DMF maintains an Active status since its submission on June 29, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 27, 2018, and payment made on June 29, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
